Micromet Gets $14M Upfront From Amgen For BiTE Technology
The world's largest biotech is investing in the research of BiTE antibodies against three undisclosed solid tumor targets.
The world's largest biotech is investing in the research of BiTE antibodies against three undisclosed solid tumor targets.